Adenosine Injection, Solution
Product Images NDC 51662-1450

7 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 51662-1450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of adenosine showing its molecular structure including nitrogenous base and sugar components, with molecular formula C10H13N5O4 and molecular weight 267.25.*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
A table listing two product variations of adenosine injection, solution 3 mg/mL. It details product numbers, NDC numbers, strengths, and vial sizes: a 2 mL fill in a 2 mL vial, and a 4 mL fill in a 5 mL vial, both in packages of 10.*
FDA Label Image
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
This packaging label is for ADENOSINE Injection, USP, 12 mg/4 mL (3 mg/mL) solution for rapid bolus intravenous use. The label specifies a 4 mL single-dose vial, sterile and preservative-free. It includes storage instructions not to refrigerate, and manufacturer information for Fresenius Kabi USA, LLC, Schaumburg, IL. A bar code and lot/expiration fields are present.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
A vial of ADENOSINE injection, USP, with a strength of 12 mg/4 mL (3 mg/mL) for intravenous use. The label states it is a single-dose vial for rapid bolus intravenous use. The labeler is HF Acquisition Co LLC, DBA HealthFirst. The vial has a gray cap and a white label with a yellow highlight for the strength information.*
FDA Label Image

Pouch Label (51662 1450 2 Pouch Label)

Pouch Label (51662 1450 2 Pouch Label)
Label for ADENOSINE Injection 3 mg/mL in a 4 mL vial, USP 12 mg/4 mL, supplied by HF Acquisition Co LLC, DBA HealthFirst. The label includes NDC 51662-1450-2, lot number, and expiration date. The product is sterile, nonpyrogenic, preservative-free, for intravenous use, with storage instructions and a warning to dissolve crystals by warming if they occur. The container closure is not made with natural rubber latex.*
FDA Label Image

Case Label (51662 1450 3 Case Label)

Case Label (51662 1450 3 Case Label)
The label for ADENOSINE injection, USP 12 mg/4 mL (3 mg/mL) solution in a 4 mL vial, packaged as a case of 10. It includes NDC 51662-1450-3, lot number, expiration date, and states use for intravenous administration. The label notes preservative-free formulation, sterility, nonpyrogenicity, and instructions for rapid bolus injection. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.